• Birinapant (TL32711): Benchmarking Apoptosis Induction in Ca

  2026-07-22

  Birinapant (TL32711) is a potent SMAC mimetic IAP antagonist that induces apoptosis in cancer models by targeting XIAP and cIAP1. Its high-affinity binding and well-defined mechanism make it instrumental for dissecting resistance pathways and optimizing chemoradiotherapy workflows. This article details molecular rationale, application boundaries, and protocol precision for Birinapant.

• Clarithromycin as a CYP3A Inhibitor: Translational Challenge

  2026-07-21

  Explore the pivotal role of clarithromycin as a CYP3A inhibitor in translational pharmacokinetic studies. This article unveils new insights into experimental strategy, evidence-driven protocol design, and the interplay with novel anticoagulants, providing depth beyond standard drug-drug interaction research.

• EdU Imaging Kits (Cy3): Precision Tools for S-Phase DNA Synt

  2026-07-21

  Explore how EdU Imaging Kits (Cy3) enable advanced, artifact-free S-phase DNA synthesis analysis for cell proliferation and genotoxicity studies. This article uniquely connects assay selection with insights from environmental carcinogen research, offering a deeper perspective on practical application.

• APOL1 Evolution, Splice Isoforms, and APOL3: Insights into R

  2026-07-20

  This article examines the molecular evolution and functional diversity of APOL1, highlighting novel findings on splice isoforms and protein–protein interactions with APOL3 that advance understanding of APOL1-driven renal cell injury. The study provides a refined framework for future research on the mechanisms underlying APOL1-associated kidney disease.

• Cy7 NHS Ester: Protocols and QC for Near-Infrared Protein La

  2026-07-20

  Cy7 NHS ester offers an effective solution for site-specific fluorescent labeling of proteins and peptides via amino group conjugation, especially in aqueous environments where protein stability is critical. Its high water solubility and reduced quenching properties make it the reagent of choice for sensitive in vitro and in vivo near-infrared imaging. However, it is not suitable for protocols requiring long-term storage of dye solutions or labeling targets lacking accessible amines.

• Methyl-β-cyclodextrin: Technical Guide for Membrane Choleste

  2026-07-19

  Methyl-β-cyclodextrin (SKU C6939) is a high-purity reagent designed for the selective extraction of cholesterol and certain lipids from biological membranes, supporting research in membrane fluidity, lipid raft dynamics, and cholesterol-dependent signaling. It is not intended for diagnostic or clinical applications, and effective use depends on careful attention to preparation, storage, and workflow protocols.

• Dextran Sulfate Sodium Salt for Refined DSS Colitis Models

  2026-07-18

  Dextran sulfate sodium salt (MW 35000-45000) from APExBIO offers reproducible and translationally relevant modeling of intestinal inflammation, enabling cutting-edge insights into epithelial repair and IBD pathogenesis. This guide details optimized experimental workflows, actionable troubleshooting, and recent mechanistic advances for researchers leveraging DSS colitis models.

• ATP Solution in mRNA and Kinase Assays: Precision in Practic

  2026-07-17

  APExBIO's ATP Solution (100 mM) empowers researchers with unmatched purity and ready-to-use convenience for sensitive kinase and mRNA workflows. This article bridges bench research and advanced therapy development, highlighting practical protocols and troubleshooting strategies that leverage ATP Solution for robust, reproducible results.

• Vancomycin Hydrochloride: Glycopeptide Antibacterial Agent W

  2026-07-17

  Vancomycin hydrochloride stands as the gold-standard glycopeptide antibacterial agent for dissecting Gram-positive bacterial resistance and pioneering reliable antibiotic susceptibility assays. This guide translates recent research and best practices into actionable workflows, advanced applications, and troubleshooting tips, empowering researchers to maximize reproducibility and innovation using APExBIO’s high-purity vancomycin hydrochloride.

• β-Elemene Inhibits Adipogenesis via AMPK Pathway in 3T3-L1 C

  2026-07-16

  This study demonstrates that β-Elemene suppresses adipogenesis in 3T3-L1 preadipocytes by activating the AMPK pathway, counteracting insulin resistance-induced lipid accumulation. These mechanistic insights provide a foundation for leveraging β-Elemene as a tool in metabolic and obesity research.

• Sanggenol L Triggers Ferroptosis in NSCLC via miR-26a-1-3p/M

  2026-07-16

  This study demonstrates that sanggenol L, derived from mulberry bark, induces ferroptosis in non-small cell lung cancer (NSCLC) cells by modulating the miR-26a-1-3p/MDM2/p53 signaling pathway. The findings provide mechanistic insight into ferroptosis-based therapies and highlight potential opportunities for targeted anti-cancer strategies.

• Transmission Dynamics of Carbapenemase Genes in CREC, 2022–2

  2026-07-15

  This study systematically characterizes carbapenemase-encoding genes (CEGs) and their transmission in carbapenem-resistant Enterobacter cloacae (CREC) across eight hospitals in Guangdong, China, during the COVID-19 pandemic. The research reveals a high prevalence of plasmid-borne blaNDM-1 genes, efficient horizontal gene transfer, and significant multidrug resistance, with important implications for infection control and molecular surveillance.

• Spermine in Eukaryotic Channel Modulation: Mechanisms and As

  2026-07-15

  Explore the pivotal role of spermine, an endogenous polyamine, in regulating inward rectifier potassium channels and advancing cellular metabolism research. This article reveals new mechanistic and practical insights, including protocol guidance and how novel findings on membrane fusion reshape experimental strategies.

• Non-Denaturing Lysis in Neuroimmunology: A New Era for Trans

  2026-07-14

  This thought-leadership article explores the mechanistic and translational significance of non-denaturing lysis buffers, with a focus on APExBIO’s NP-40 Lysis Buffer, in advancing research on FPR2/ALX signaling and neuroinflammation. Bridging protein extraction fidelity with experimental rigor, it offers protocol guidance for diverse cell types and provides strategic insights for translational researchers seeking next-generation immunomodulatory therapies.

• JZL184: Mechanistic Precision for Endocannabinoid Modulation

  2026-07-14

  Explore the mechanistic underpinnings and strategic applications of JZL184, a selective monoacylglycerol lipase inhibitor, in translational neuroscience. This thought-leadership article integrates recent advances in endocannabinoid signaling and CB1-mediated synaptic modulation, highlighting JZL184’s role in dissecting the interplay between neuroprotection, glutamate homeostasis, and behavioral outcomes after traumatic brain injury (TBI). Discover protocol guidance, competitive context, and translational outlooks for researchers navigating the evolving landscape of neuropharmacology.

10322 records 3/689 page Previous Next 12345 下5页 Last page